Design Scheme for Separation and Purification Process of Biological Fermentation Broth
Design Scheme for Separation and Purification Process of Biological Fermentation Broth
1.0 Design Basis and Objectives
-
Processing Target: Fermentation broth from microorganisms (bacteria, yeast, fungi) or animal/plant cells.
-
System Characteristics:
-
Complex Composition: Contains target product (antibiotics, enzymes, proteins, organic acids, polysaccharides, etc.), biomass/cells, residual culture medium components (proteins, sugars, inorganic salts), metabolic by-products, pigments.
-
Diversity of Target Products: Vast differences in molecular weight, charge, hydrophobicity, and stability.
-
High Stability Requirements: Most biological products are sensitive to temperature, pH, and shear forces, prone to inactivation or degradation.
-
-
Design Principles:
-
High Recovery and High Purity: Maximize yield and purity while maintaining product bioactivity.
-
Multi-stage Separation: Employ a strategy of "from crude to fine, stepwise purification," typically following the sequence: "Solid-Liquid Separation → Preliminary Concentration & Clarification → Intermediate Purification → Fine Purification → Finishing."
-
Process Integration and Optimization: Rationally combine physical, chemical, and biological separation methods based on product characteristics to optimize process efficiency and cost.
-
2.0 General Process Flow Design
The separation and purification of biological fermentation products is a multi-step, multi-technology integrated process. Its core separation workflow can be summarized in the following steps:

Step-by-Step Process Explanation:
Stage 1: Fermentation Broth Pretreatment and Solid-Liquid Separation
-
Purpose: Alter the physical properties of the broth to facilitate subsequent separation and achieve initial isolation of the target product from the culture system.
-
Pretreatment:
-
pH and Temperature Adjustment: Bring the system to conditions optimal for product stability and separation.
-
Flocculation/Coagulation: Add electrolytes or polymeric flocculants to aggregate cells, mycelia, or colloidal particles, facilitating sedimentation or filtration.
-
-
Solid-Liquid Separation:
-
For Extracellular Products: Primarily remove biomass/cells to obtain clarified liquor. Techniques include plate & frame filtration, centrifugation (disc-stack centrifuge), tangential flow microfiltration.
-
For Intracellular Products: First harvest biomass/cells (centrifugation or membrane filtration), then perform cell disruption (high-pressure homogenization, bead milling, enzymatic lysis), followed by solid-liquid separation to remove cell debris (high-speed centrifugation or depth filtration).
-
Stage 2: Initial Concentration and Capture
-
Purpose: Significantly reduce volume, achieve preliminary enrichment of the target product, and remove a large portion of impurities.
-
Membrane Separation: Ultrafiltration for concentration and rough screening based on molecular weight; Nanofiltration for desalting and concentrating small molecule products.
-
Precipitation: Utilize salting-out (e.g., ammonium sulfate), isoelectric point precipitation, or organic solvent precipitation for selective precipitation of the target product.
-
Extraction:
-
Liquid-Liquid Extraction: Suitable for small molecules, antibiotics (e.g., penicillin).
-
Aqueous Two-Phase Extraction: Suitable for proteins, enzymes; gentle conditions, easily scalable.
-
Reverse Micelle Extraction / Supercritical Fluid Extraction: Specialized extraction for high-value products.
-
Stage 3: Intermediate Purification
-
Purpose: Remove impurities with similar structure and properties based on product specificity, achieving high purification factors.
-
Chromatography Techniques:
-
Ion Exchange Chromatography: Separation based on charge differences; high capacity, core technology for purifying proteins, nucleic acids.
-
Hydrophobic Interaction Chromatography: Separation based on hydrophobicity differences; often used for fine separation after ion exchange.
-
Affinity Chromatography: Utilizes specific biological interactions (e.g., antigen-antibody, enzyme-substrate); extremely high purification efficiency, but media is expensive.
-
Stage 4: Fine Purification and Finishing
-
Purpose: Remove trace impurities (e.g., host cell proteins, DNA, endotoxins) to meet final purity requirements.
-
Gel Filtration (Size Exclusion) Chromatography: Separation based on molecular size differences; also functions for desalting and buffer exchange.
-
Reversed-Phase Chromatography / High-Performance Liquid Chromatography: Used for final polishing, especially for small peptides, antibiotics.
-
Finishing:
-
Ultrafiltration / Dialysis: Concentrate and exchange into final formulation buffer.
-
Lyophilization (Freeze-drying): For thermolabile products, convert to dry powder for long-term storage.
-
3.0 Key Technology Selection and Comparison
|
Separation Stage |
Optional Technologies |
Principle |
Advantages |
Limitations |
Applicable Product Types |
|---|---|---|---|---|---|
|
Solid-Liquid Separation |
Disc-Stack Centrifugation |
Density difference, Centrifugal force |
High throughput, Continuous operation |
High energy consumption, Limited efficiency for fine particles |
Bacterial, Yeast biomass |
|
Tangential Flow Microfiltration |
Sieving |
High resolution, Gentle conditions, Closed operation |
Membrane fouling, Flux decline |
Cell harvest, Biomass separation |
|
|
Initial Concentration |
Ultrafiltration |
Molecular weight cut-off |
Ambient temperature, No phase change, Easily scalable |
Membrane fouling, Concentration polarization |
Proteins, Enzymes, Polysaccharides |
|
Precipitation (Salting-out/Solvent) |
Solubility difference |
Simple equipment, High throughput, Low cost |
Low resolution, Requires desalting, May cause inactivation |
Antibodies, Some enzymes |
|
|
Intermediate Purification |
Ion Exchange Chromatography |
Charge interaction |
High capacity, High resolution, Moderate cost |
Sensitive to pH and ionic strength |
Most charged biomolecules |
|
Affinity Chromatography |
Specific biological binding |
Very high purification factor, Effective one-step purification |
Expensive ligand, Prone to inactivation, Complex cleaning/regeneration |
Proteins with specific ligands (e.g., Antibodies) |
|
|
Fine Purification |
Gel Filtration Chromatography |
Molecular size exclusion |
Gentle conditions, Can desalt/exchange buffer |
Small loading capacity, Dilutes sample |
Final polishing, Aggregate removal |
|
Reversed-Phase Chromatography |
Hydrophobicity partitioning |
Very high resolution |
Uses organic solvents, may denature proteins |
Small peptides, Antibiotics |
4.0 Key Process Parameters and Control Strategy
-
Process Integration and Interfacing: Optimize buffer conditions (pH, ionic strength) between unit operations to minimize sample handling and conditioning steps.
-
Maintenance of Bioactivity:
-
Temperature: Operate at low temperatures throughout (typically 4-10°C).
-
Time: Minimize processing time, especially under harsh conditions (e.g., extreme pH, organic solvents).
-
Inhibition of Degradation: Add protease inhibitors, antioxidants, etc.
-
-
Cleaning and Hygiene: For pharmaceutical-grade products, comply with cGMP requirements. All equipment must have CIP/SIP capabilities to prevent microbial contamination and cross-contamination.
-
Online Monitoring and Control: Employ online pH, conductivity, UV, biosensors, etc., for real-time monitoring of product concentration and impurity levels, enabling process automation and digitization.
5.0 Scheme Summary
This scheme provides a modular, customizable general framework for the separation and purification of biological fermentation broths. The key to success lies in selecting and optimizing the combination sequence and operating parameters of the aforementioned unit operations based on the specific physicochemical properties (molecular weight, isoelectric point, stability, hydrophobicity) and purity/activity requirements of the target product.
Recommended Implementation Path:
-
Laboratory-Scale Feasibility: Determine the basic properties of the product and screen for the optimal combination of separation methods.
-
Process Development: Optimize operating parameters for each step (e.g., chromatography elution gradient, membrane operating pressure) at a 1-10L scale.
-
Pilot-Scale Up: Validate process robustness, yield, and cost on scaled equipment, addressing engineering scale-up issues (e.g., fluid distribution, mass transfer efficiency).
-
Production Design: Based on pilot data, design a GMP-compliant production line, including equipment selection, P&ID development, automation control, and validation protocols.

